Citigroup’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-23,901
Closed -$146K 5387
2021
Q3
$146K Sell
23,901
-264,527
-92% -$1.62M ﹤0.01% 3524
2021
Q2
$2.37M Buy
288,428
+108,353
+60% +$892K ﹤0.01% 1977
2021
Q1
$1.61M Buy
180,075
+157,888
+712% +$1.41M ﹤0.01% 2061
2020
Q4
$256K Buy
22,187
+17,571
+381% +$203K ﹤0.01% 3088
2020
Q3
$48K Sell
4,616
-38,809
-89% -$404K ﹤0.01% 3511
2020
Q2
$571K Buy
43,425
+3,313
+8% +$43.6K ﹤0.01% 2471
2020
Q1
$316K Sell
40,112
-25,872
-39% -$204K ﹤0.01% 2571
2019
Q4
$1.37M Sell
65,984
-76,805
-54% -$1.59M ﹤0.01% 1958
2019
Q3
$1.96M Buy
142,789
+67,840
+91% +$929K ﹤0.01% 1628
2019
Q2
$922K Buy
74,949
+36,406
+94% +$448K ﹤0.01% 2201
2019
Q1
$480K Sell
38,543
-221,209
-85% -$2.75M ﹤0.01% 2522
2018
Q4
$2.94M Buy
259,752
+171,605
+195% +$1.94M ﹤0.01% 1314
2018
Q3
$1.65M Buy
88,147
+22,251
+34% +$417K ﹤0.01% 1633
2018
Q2
$1.7M Sell
65,896
-12,215
-16% -$316K ﹤0.01% 1556
2018
Q1
$1.75M Sell
78,111
-49,396
-39% -$1.11M ﹤0.01% 1507
2017
Q4
$3.19M Buy
127,507
+92,185
+261% +$2.31M ﹤0.01% 1198
2017
Q3
$854K Sell
35,322
-2,768
-7% -$66.9K ﹤0.01% 2046
2017
Q2
$770K Buy
38,090
+22,969
+152% +$464K ﹤0.01% 2149
2017
Q1
$407K Sell
15,121
-13,571
-47% -$365K ﹤0.01% 2533
2016
Q4
$546K Buy
28,692
+26,194
+1,049% +$498K ﹤0.01% 2824
2016
Q3
$49K Sell
2,498
-756
-23% -$14.8K ﹤0.01% 3743
2016
Q2
$48K Sell
3,254
-7,587
-70% -$112K ﹤0.01% 3720
2016
Q1
$100K Buy
10,841
+5,834
+117% +$53.8K ﹤0.01% 3936
2015
Q4
$97K Buy
5,007
+5,005
+250,250% +$97K ﹤0.01% 3605
2015
Q3
$0 Sell
2
-214
-99% ﹤0.01% 5685
2015
Q2
$5K Sell
216
-4,614
-96% -$107K ﹤0.01% 4876
2015
Q1
$109K Buy
4,830
+3,748
+346% +$84.6K ﹤0.01% 3352
2014
Q4
$22K Buy
1,082
+875
+423% +$17.8K ﹤0.01% 4554
2014
Q3
$4K Buy
207
+169
+445% +$3.27K ﹤0.01% 5032
2014
Q2
$1K Buy
38
+16
+73% +$421 ﹤0.01% 5354
2014
Q1
$0 Buy
+22
New ﹤0.01% 5634